Ablation is a minimally invasive surgical technique that involves destruction or removal of dysfunctional tissues to treat life-threatening diseases such as cancers, atrial fibrillation, etc. It is also equally adopted for simple treatments in cosmetology, orthopedics, uterine fibroids, etc. There is an increase in prevalence and incidents rates of lifestyle-oriented diseases and an increasing need to innovate minimally and noninvasive technologies to treat them. About 15% to 20% of ischemic strokes occur due to atrial fibrillation and about 12 million people in the U.S. are expected to suffer from this condition by 2050. Deaths due to cancers are reaching alarming rates across the globe. With numerous technologies available to control and treat cardiovascular disorders and cancer, these diseases still remain primary causes of death. Where conventional radiation therapies have been effective and been adopted due to high awareness levels, emerging technologies such as hydromechanical ablation, microwave and hydrothermal are increasing hopes among patients and healthcare service providers.
An increasingly aging population on one side and increasing healthcare expenditure on the other is becoming a major burden to governments across various countries. The regulatory and financial environment is getting significantly complex even in developed economies with governments focusing on cost-containment measures. The ablation procedure in this scenario is expected to be significantly preferred due to cost effectiveness (in comparison to conventional surgical techniques), shorter hospital stays, short recovery time, and lesser risk of blood loss and infections.
A high level of economic instability, growing pockets of investment in developing economies and commercialization of next-generation technologies are compelling market participants to collaborate and leverage. The current scenario requires the market players to plan exclusive strategies after an in-depth understanding of geographic, regulatory, technology and other key market factors.
SCOPE OF THE REPORT
This research report presents an in-depth analysis of the global ablation market by technologies, product categories, therapeutic segments, key procedures and geographic markets. The report includes key technologies involved in thermal ablation techniques and nonthermal ablation techniques. The report discusses the role of supply chain members from manufacturers to surgeons. The report has an in-depth analysis of key companies operating in the global ablation market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe and Japan.
The ablation devices market is mainly segmented into two classes: thermal and nonthermal technologies. Thermal technologies are further segmented into electrical, radiation, radio frequency, light, ultrasound, microwave and hydrothermal. The nonthermal technology market is segmented into cryotherapy and hydromechanical. The ablation devices technology market is further segmented on the basis of products offered for in-depth analysis of technology markets during the analysis period. The market study is detailed for technology based on procedures as well as its further implication on the therapeutic area. These two segmentations are also discussed in detail for the given period. The market is segmented by geography into the North America, Europe, Asia-Pacific and ROW. Companies profiled in this report include Conmed, Varian Medical Systems Inc., Medtronic Inc., Boston Scientific Corp., Olympus Corp., Smith & Nephew, C.R. Bard Inc., and others.
The intended audience includes:
- Ablation technologies and device manufacturers and potential entrants.
- Dealers, distributors and service providers of ablation devices.
- Robotics, life science and surgical companies.
- Healthcare-oriented software and analytics companies.
- Research institutes, associations and academicians.
SOURCE OF INFORMATION AND METHODOLOGY
The global ablation market was assessed and calculated through a bottom-up approach that involved identifying the market revenues of the micromarkets that make up the macromarkets. The following process was followed to ensure quality and consistency of estimates.
- In-depth primary and secondary research was conducted.
- Primary research included gathering intelligence from key market players. The participants of the interview include chief executive officers, key opinion leaders, product heads and directors.
- Secondary research not only included collation of data from freely available sources but also paid subscriptions from specialized industry magazines and websites.
- To best assure triangulation of market estimates, the derived values where again validated through primary research.
- Key factors considered during market estimations were price, volumes, incidence and prevalence rates, number of procedures, etc.
- The geographic segmentation was assessed through various parameters such as the number of players in a particular region, incidence and prevalence rates, the extent of research activity occurring in that geography and future potential.
Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, the life sciences market and the chemical domain. She has frequently delivered research services that contain strategic recommendations and top business strategies to assist the market players to make beneficial strategies. Ms. Jeevane holds an MBA in marketing.
Download the full report: https://www.reportbuyer.com/product/2009158/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ablation-devices-technologies-and-global-markets-300386001.html